Document is current
Any future updates will be listed below
-
Authors
Deycmar, Simon http://orcid.org/0000-0002-1312-5051
Johnson, Brendan J.
Ray, Karina
Schaaf, George W.
Ryan, Declan Patrick
Cullin, Cassandra
Dozier, Brandy L.
Ferguson, Betsy
Bimber, Benjamin N.
Olson, John D.
Caudell, David L.
Whitlow, Christopher T.
Solingapuram Sai, Kiran Kumar
Romero, Emily C.
Villinger, Francois J.
Burgos, Armando G.
Ainsworth, Hannah C.
Miller, Lance D.
Hawkins, Gregory A.
Chou, Jeff W.
Gomes, Bruno
Hettich, Michael
Ceppi, Maurizio
Charo, Jehad
Cline, J. Mark
-
Funding
Funding for this research was provided by:
Roche (RPF-ID541)
National Institutes of Health (T32OD010957, UL1TR001420, T35OD010946, P51OD011092, U42OD010426, R24OD021324, P40OD012217, R24OD010947)
National Cancer Institute (P30CA012197)
- License Information
-
More Information
Article History
Received: 25 August 2023
Accepted: 8 January 2024
First Online: 19 March 2024
Declarations
:
: All procedures were approved by the WFUSM Institutional Animal Care and Use Committee, in compliance with the U.S. Animal Welfare Act, The Guide for the Care and Use of Laboratory Animals, the Office of Laboratory Animal Welfare, and Public Health Service Policy. WFUSM is accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care, International (AAALAC).
: Not applicable.
: Simon Deycmar is a beneficiary of the Roche Postdoctoral Fellowship program (RPF-ID541) and J Mark Cline has received funding from Roche. Bruno Gomes, Michael Hettich, and Jehad Charo are employees and stockholders of Roche. Maurizio Ceppi was an employee of Roche and is currently employed at iTeos Therapeutics (Gosselies, Belgium). Thus, there are no direct known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
